Baricitinib as potential treatment for 2019-nCoV acute respiratory disease (vol 395, pg e30, 2020)

被引：1

作者：

Richardson, Peter

Griffin, Ivan

Tucker, Catherine

Smith, Dan

Oechsle, Olly

Phelan, Anne

Rawling, Michael ^{[1
]}

Savory, Edward ^{[1
]}

Stebbing, Justin

机构：

[1] BenevolentAI, London, England

来源：

LANCET | 2020年 / 395卷 / 10241期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1906 / 1906

页数：1

共 43 条

[21] Reduced antibiotic use after initial treatment of acute respiratory infections with phytopharmaceuticals-A retrospective cohort study (vol 132, pg 412, 2020)
Martin, D.
Konrad, M.
Adarkwah, Christian C.
Kostev, K.
POSTGRADUATE MEDICINE, 2020,
[22] Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study (vol 30, pg 357, 2020)
Brito, J. P.
THYROID, 2020, 30 (06) : 938 - 938
[23] Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension? (vol 318, pg E587, 2020)
Cadegiani, F. A.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2021, 320 (05): : E1006 - E1006
[24] Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline (vol 71, pg e1, 2020)
Daley, C. L.
Iaccarino, J. M.
Lange, C.
CLINICAL INFECTIOUS DISEASES, 2020, 71 (11) : 3023 - 3023
[25] Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine Recipients (vol 75, pg 1652, 2019)
Woldemeskel, Bezawit A.
Garliss, Caroline C.
Aytenfisu, Tihitina Y.
Johnston, Trevor S.
Cox, Andrea L.
Karaba, Andrew H.
Blankson, Joel N.
CLINICAL INFECTIOUS DISEASES, 2024, 78 (05) : 1389 - 1389
[26] Therapeutic Challenges in Patients With Noncardioembolic Acute Ischemic Stroke in Need of Double Antiplatelet Therapy for Coronary Artery Disease (vol 26, pg e213, 2019)
Darabont, Roxana Oana
Stoicescu, C.
Tiu, C.
AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (03) : E431 - E431
[27] Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease (vol 50, pg 628, 2019)
Koopman, N.
Molinaro, A.
Nieuwdorp, M.
Holleboom, A. G.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (10) : 1142 - 1142
[28] Evaluation of α-Synuclein and Apolipoprotein E as Potential Biomarkers in Cerebrospinal Fluid to Monitor Pharmacotherapeutic Efficacy in Dopamine Dictated Disease States of Parkinson's Disease and Schizophrenia (vol 15, pg 2073, 2019)
Gupta, A. K.
Pokhriyal, R.
Das, U.
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 1271 - 1271
[29] Acute Respiratory Events and Dosimetry of Total Body Irradiation Patients Using in Vivo Lung Dose Monitoring and Custom Lung Block Adaptation (vol 10, pg e397, 2020)
Jang, J. K.
Reilly, M.
Yaghmour, G.
Rashid, F.
Ballas, L. K.
PRACTICAL RADIATION ONCOLOGY, 2021, 11 (02) : E245 - E245
[30] Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019 (vol 26, pg 1, 2022)
Guisado-Vasco, P.
Gorines, J. Aguareles
Gonzalez, M. M. Carralon
JOURNAL OF INFECTIOUS DISEASES, 2023, 227 (08): : 1023 - 1023

← 1 2 3 4 5 →